China Pharma Holdings Inc   (CPHI)
Other Ticker:  


China Pharma Holdings Inc

CPHI's Financial Statements and Analysis

China Pharma Holdings Inc increased III. Quarter net loss per share of $-0.02 compare to net loss per share of $-0.02 recorded in the same quarter a year ago a decrease compare to $-0.02 realized in previous quarter.

III. Quarter
Earnings Per Share Revenues
$ -0.02 $  2 Mill
Unch.     Unch.     -0.64 %

China Pharma Holdings Inc 's Revenue fell by -0.64 % in III. Quarter (Sep 30 2022) year on year, to $2 million and advanced by 21.87 % sequentially.

China Pharma Holdings Inc is Expected to report next financial results on March 29, 2023.

More on CPHI's Income Statement

China Pharma Holdings Inc 's in III. Quarter recorded net loss of $-0.791 million, an improvement compare to net loss of $-0.827 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-0.888 million realized in previous quarter.

More on CPHI's Growth

Inventories declined by -6.08 % to $2.89 million from III. Quarter a year ago, sequentially inventories fell by -18.23 %. In III. Quarter company's net cash and cash equivalents decreased by $0 million, capital expenditures grew by -39.29%, to $0 millions compare to same quarter a year ago and fell by 44.07% from II. Quarter (Jun 30 2022).

More on CPHI's Cash flow Statement

China Pharma Holdings Inc does not pay out common stock dividend.

In trailing twelve-month period China Pharma Holdings Inc payed $ -0.02 cash per share, on a free-cash flow basis .